DARE Price / Book | Dare Bioscience, Inc.

Dare Bioscience, Inc. (DARE) Price / Book

2026-03-31: Price/Book Ratio 36.08.
2025-12-31: Price/Book Ratio 9.84.
2025-09-30: Price/Book Ratio 10.24.
2024-06-30: Price/Book Ratio 12.9.

Historical market capitalization divided by filed shareholder equity.

Available history: 2014-06-30 to 2026-03-31
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-03-31	36.08
2025-12-31	9.84
2025-09-30	10.24
2024-06-30	12.9
2023-03-31	216.33
2022-12-31	76.03
2022-09-30	38.24
2022-06-30	37.51
2022-03-31	48.61
2021-12-31	51.99
2021-09-30	48.14
2021-06-30	168.14
2021-03-31	294.49
2020-06-30	1,087.61
2020-03-31	78.39
2019-12-31	439.37
2019-09-30	86.27
2019-06-30	33.48
2019-03-31	50.76
2018-12-31	14.49
2018-09-30	13.94
2018-06-30	13.13
2018-03-31	7.26
2017-12-31	11.81
2017-09-30	10.1
2017-06-30	38.11
2017-03-31	365.31
2016-09-30	207.03
2016-06-30	269.4
2016-03-31	247.3
2015-09-30	204.81
2015-06-30	220.96
2015-03-31	550.34
2014-12-31	331.41
2014-09-30	194
2014-06-30	242.28

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
KIORA PHARMACEUTICALS INC (KPRX)	United States	$0.012B
Scienture Holdings, Inc. (SCNX)	United States	$0.012B	-0.38
Phio Pharmaceuticals Corp. (PHIO)	United States	$0.012B	-0.92
ADIAL PHARMACEUTICALS, INC. (ADIL)	United States	$0.012B
Moleculin Biotech, Inc. (MBRX)	United States	$0.011B
MetaVia Inc. (MTVA)	United States	$0.011B	-0.65
KALA BIO, Inc. (KALA)	United States	$0.011B	-3.33
BIOVIE INC. (BIVI)	United States	$0.012B
Theriva Biologics, Inc. (TOVX)	United States	$0.011B
Aspire Biopharma Holdings, Inc. (ASBP)	United States	$0.012B	-0.60